Blue California Commercializes Nicotinamide Mononucleotide (NMN) For Supporting An Increased Healthspan

A better cost-effective option is now available for dietary supplement, functional food, and beverage manufacturers.

Rancho Santa Margarita, Calif., July 21 (Bernama-GLOBE NEWSWIRE) — Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of high-purity, fermentation-derived nicotinamide mononucleotide (NMN). A nature-based metabolic component which has caught the attention of health-conscious consumers for supporting energy and longevity.

http://mrem.bernama.com/viewsm.php?idm=40571

administrator

Related Articles